New Paths in Respiratory Sleep Medicine: Consumer Devices, e-Health, and Digital Health Measurements
- PMID: 34711386
- DOI: 10.1016/j.jsmc.2021.08.006
New Paths in Respiratory Sleep Medicine: Consumer Devices, e-Health, and Digital Health Measurements
Abstract
Sleep health and tracking sleep with contemporary wearables have become more popular. Sleep disorders, in particular, sleep-disordered breathing, have a higher prevalence than estimated previously. Many patients with apnea and hypopnea events suffer whereas others do not report complaints or show cardiovascular consequences. Assessment with wearables may support efforts to distinguish which type of apnea is related to aging and which to cardiovascular comorbidities. Innovative methods offer smart solutions for problems that are insufficiently addressed. Telemedical concepts help bring patients to sleep medicine expertise at an early stage. To use these methods clinically, they must be certified as medical devices.
Keywords: Diagnostics; E-health; Health apps; Longtime monitoring; Out-of-center testing; Sleep-disordered breathing.
Copyright © 2021 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure T. Penzel has received speaker fees from Jazz Pharma, Löwenstein Medical, and Neuwirth Medizintechnik. He has received consulting fees from Bayer Healthcare, Cerebra Inc, Jazz Pharma, and National Sleep Foundation. He owns shares of Advanced Sleep Research, The Siestagroup GmbH, and Nukute Oy. S. Dietz-Terjung reports no conflict of interest. H. Woehrle is chair of the workgroup on Digitalization of the Federal association of pneumologists in Germany and vice chair of the section sleep medicine of the German society for pneumology. He has received speaker fees and consultation fees from Astra Zeneca, Allergopharma, Bioproject, Boehringer Ingelheim, Chiesi, GSK, Novartis, Inspire, Jazz, ResMed, and Sanofi and research grants from ResMed and Novartis. C. Schöbel reports institutional research grants and institutional financial recompensation for lectures and advisory boards by AstraZeneca, Bayer, BerlinChemie, Bristol-Myers Squibb, JAZZ Pharmaceutical, Novamed, Novartis, ResMed, and Sleepiz. C. Schöbel is member of the board of German Sleep Society (DGSM) and Head of the task force Telemedicine of German Society for Internal Medicine (DGIM).
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
